ISICOM

Main information

  • Trade name:
  • ISICOM Tablet 250MG/25MG
  • Dosage:
  • 250MG/25MG
  • Pharmaceutical form:
  • Tablet
  • Administration route:
  • Oral use
  • Units in package:
  • 100 Blister
  • Prescription type:
  • with prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ISICOM Tablet 250MG/25MG
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • LEVODOPA AND AN INHIBITOR OF DEKARBOXYLASY
  • Product summary:
  • ISICOM 250 MG

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization status:
  • R - active MA/authorised medicinal product
  • Authorization number:
  • 27/ 155/91-C/PI/001/14
  • EAN code:
  • 8594172160430
  • Last update:
  • 05-04-2018

7-8-2018

Numient (Impax Laboratories Ireland Limited)

Numient (Impax Laboratories Ireland Limited)

Numient (Active substance: levodopa / carbidopa) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)5418 of Tue, 07 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2611/T/5

Europe -DG Health and Food Safety

10-7-2018

Corbilta (Orion Corporation)

Corbilta (Orion Corporation)

Corbilta (Active substance: levodopa / carbidopa / entacapone) - Centralised - Renewal - Commission Decision (2018)4468 of Tue, 10 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2785/R/15

Europe -DG Health and Food Safety